ClinicalTrials.gov
public full text
Public Domain
A Study to Assess Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy (CBT) in Conjunction With Esketamine in Participants With Treatment-resistant Depression
The purpose of this study is to explore feasibility of combining clinician-directed cognitive behavioral therapy (CBT) supplemented with the Mindset app with esketamine therapy in participants with Treatment-resistant Depression.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Combined Effect of TCC-I and BATD on Depressive Symptoms and Insomnia#1059994
- Efficacy of an App-based CBT Featuring Virtual Reality for Anxiety Disorders#899184
- Impact of Web-Based Cognitive Bias Modification for Threat Interpretations on Depressive Symptoms Among Anxious Adults with Co-Occurring Depressive Symptoms#251660
- A Clinical Decision Support Tool for Electronic Health Records#892486
- Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant Depression#861433
Record · ID 968194
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive